Evidence map›Paper›PMID 38130367›Full record

ArticleJournal of vascular surgery cases and innovative techniques2024

Human gelatin thrombin matrix with rifampin for the treatment of prosthetic vascular graft infections.

José L Ortiz-Fullana, Cristina Sánchez, Pedro Pagán, Patricia Mulero-Soto, Gabriel Dieppa-Barnes, Rafael Santini-Domínguez, Jorge L Martinez-Trabal

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of vascular surgery cases and innovative techniques, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

José L Ortiz-FullanaDepartment of Vascular Surgery, San Luke's Memorial Hospital, Ponce, Puerto Rico.
Cristina SánchezSchool of Medicine, Ponce Health Sciences University, Ponce, Puerto Rico.
Pedro PagánSchool of Medicine, Ponce Health Sciences University, Ponce, Puerto Rico.
Patricia Mulero-SotoDepartment of Vascular Surgery, San Luke's Memorial Hospital, Ponce, Puerto Rico.
Gabriel Dieppa-BarnesDepartment of Vascular Surgery, San Luke's Memorial Hospital, Ponce, Puerto Rico.
Rafael Santini-DomínguezDepartment of Vascular Surgery, San Luke's Memorial Hospital, Ponce, Puerto Rico.
Jorge L Martinez-TrabalDepartment of Vascular Surgery, San Luke's Memorial Hospital, Ponce, Puerto Rico.
Memorial Hospital · USPonce Health Sciences University · PR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We aim to describe and report on a novel graft preservation technique using a human gelatin thrombin matrix with rifampin for the treatment of vascular graft infections. Eight patients with vascular graft infections were included, one with bilateral infections, for a total of nine cases from January 2016 through June 2021. All the patients underwent wound exploration and placement of human gelatin thrombin matrix with rifampin. No deaths or allergic reactions had been reported at the 30-day follow-up, with only one major amputation. The graft and limb salvage rates were 77.8% at the 1-year follow-up. The mean time to a major amputation was 122 days, and the mean time to graft excision was 30 days.

Indexed as

Bioabsorbable antibioticsExpanded polytetrafluoroethylene graftsHGTMHuman thrombin-gelatin matrixProsthetic graft infectionsRifampinVascular graft infectionVGI

Identifiers

PMID38130367
PMCPMC10731601
OpenAlexW4388346892

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.